Bank of Montreal
KRYS icon

Bank of Montreal’s Krystal Biotech KRYS Stock Holding History

Bank of Montreal’s Portfolio KRYS Stock Details KRYS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.22M Buy
3,291
+129
+4% +$38.5K ﹤0.01% 1978
2026
Q1 		$817K Buy
3,162
+931
+42% +$248K ﹤0.01% 2151
2025
Q4 		$550K Sell
2,231
-98
-4% -$20.6K ﹤0.01% 2265
2025
Q3 		$411K Sell
2,329
-2,078
-47% -$311K ﹤0.01% 2360
2025
Q2 		$606K Sell
4,407
-11
-0.2% -$1.62K ﹤0.01% 2171
2025
Q1 		$797K Buy
4,418
+1,093
+33% +$184K ﹤0.01% 1928
2024
Q4 		$521K Buy
3,325
+179
+6% +$31.8K ﹤0.01% 2210
2024
Q3 		$557K Buy
3,146
+210
+7% +$40.5K ﹤0.01% 2344
2024
Q2 		$540K Buy
+2,936
New +$493K ﹤0.01% 2354
2023
Q1 		– Sell
-21,698
Closed -$1.76M – 3999
2022
Q4 		$1.76M Buy
21,698
+60
+0.3% +$4.45K ﹤0.01% 1848
2022
Q3 		$1.55K Buy
+21,638
New +$1.56M ﹤0.01% 1962
2021
Q2 		– Sell
-491
Closed -$37K – 4338
2021
Q1 		$37K Sell
491
-1,603
-77% -$117K ﹤0.01% 3828
2020
Q4 		$139K Buy
2,094
+1,468
+235% +$73.3K ﹤0.01% 3411
2020
Q3 		$29K Sell
626
-333
-35% -$14.5K ﹤0.01% 3659
2020
Q2 		$41K Buy
+959
New +$46.1K ﹤0.01% 3519
2020
Q1 		– Sell
-1,326
Closed -$73K – 4402
2019
Q4 		$73K Buy
1,326
+406
+44% +$19.9K ﹤0.01% 3646
2019
Q3 		$32K Buy
920
+189
+26% +$8.45K ﹤0.01% 3829
2019
Q2 		$29K Buy
+731
New +$23.9K ﹤0.01% 3951

Other funds holding KRYS

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $11.1B AUM 207.82% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
SCM
Soleus Capital Management Greenwich, Connecticut $2.9B AUM 169.69% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HRCM
Hood River Capital Management Palm Beach Gardens, Florida $13.8B AUM 163.97% 1-Year Est. Return

Bank of Montreal's KRYS Position: Q2 2026 in Review

Bank of Montreal increased its Krystal Biotech (KRYS) stake by 4.1% in Q2 2026, buying an estimated $38.5K and bringing the position to 3,291 shares worth $1.22M. The position accounts for ﹤0.01% of the portfolio, ranked #1978.

Bank of Montreal first reported a position in KRYS in Q2 2019 and has held it in 18 quarters since. The position peaked at $1.76M in Q4 2022. 398 funds tracked by Wall St. Rank hold KRYS as of Q2 2026.

  • Bank of Montreal held 3,291 shares of Krystal Biotech worth $1.22M as of Q2 2026.
  • Bank of Montreal bought 129 Krystal Biotech shares in Q2 2026, an estimated $38.5K.
  • Krystal Biotech made up ﹤0.01% of Bank of Montreal's portfolio in Q2 2026, its #1978 holding.
  • Bank of Montreal first reported a position in Krystal Biotech in Q2 2019 and has held it in 18 quarters since.
  • Bank of Montreal's Krystal Biotech position peaked at $1.76M in Q4 2022.
  • 398 funds tracked by Wall St. Rank held Krystal Biotech as of Q2 2026.

Based on Bank of Montreal's 13F filing for Q2 2026, filed 12 Aug 2026.